russia coronavirus vaccine sputnik: Russia starts giving Sputnik-V corona vaccine, clinics lying vacant in their own country – low number of people turning up for sputnik v coronavirus vaccine shot in russia

There has been mixed reactions of people on the ‘Sputnik-V’ vaccine developed in Russia. Health workers and teachers are being vaccinated in the first phase, but people are not coming to Moscow to apply for the vaccine at many clinics. After the Russian government and media approved the ‘Sputnik-V’ vaccine on August 11, it was described as a major achievement, but there is not a very enthusiastic response among the general public about the vaccine and many people believe it to be effective and safe. Are expressing doubts about it.

Russia’s criticism

Russia has also faced criticism for not completing all phases of experimental testing. Experts from within the country and abroad also warned against widespread use of the vaccine till its completion. At the same time, the administration, ignoring suggestions, started giving vaccines to at-risk groups, including health workers working on the advance fronts. Alexander Gintzberg, head of the Gamalaya Institute that developed the vaccine, said last week that more than one and a half million people in Russia had been given vaccine doses.

Precaution after vaccine

ICU specialist Alexander Justsepine also took the vaccine dose in Voronezh, about 500 km from Moscow. He said that despite taking the vaccine, he is taking precaution because the study about its effect has not been completed yet. The UK approved Pfizer’s vaccine on 2 December. After this, Russia also started vaccination on a large scale due to the fear of being left behind in the competition for vaccine manufacture.

Being given to people aged 18-60


Russia approved the vaccines developed in its country only after clinical trials on a few dozen people. The vaccine makers named it ‘Sputnik-V’. In this way, its reference was linked to the first satellite left by the Soviet Union in 1957 during the Cold War. In the UK, vaccine doses are first given to the elderly, while ‘Sputnik-V’ is being given to people between the ages of 18 and 60.

91% effective vaccine


Vaccine manufacturers said the study showed that the sputum vaccine was 91 percent effective. This result was derived from a study conducted on about 23,000 participants, while Western countries included more people, people of different backgrounds, ages, in the test. Levada Center, an independent survey organization in Russia, conducted an opinion poll in October, with 59 per cent saying they would not want to take the vaccine despite being offered it. Talking to some health workers and teachers led to the fact that they did not want to take the vaccine due to not being tested properly.

Leave a Comment